Axim Biotechnologies, Inc.
AXIM- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001514946
No open-market purchases or sales by Axim Biotechnologies, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of AXIM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Axim Biotechnologies, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Axim Biotechnologies, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Axim Biotechnologies, Inc., newest first.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 23, 2022 | Juniper & Ivy Corp | 13DOld format | – | New | – | SEC |
| Aug 31, 2022 | Valencia Catalina | 13D/AOld format | – | – | – | SEC |
| Aug 31, 2022 | Glycodots, LLC | 13DOld format | – | New | – | SEC |
| Aug 31, 2022 | Valencia Catalina | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Axim Biotechnologies, Inc. shares.
No Form 144 notices for Axim Biotechnologies, Inc. are on file.